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Abstract
Purpose Accurate attenuation correction (AC) is essential for
quantitative analysis of PET tracer distribution. In MR, the
lack of cortical bone signal makes bone segmentation difficult
and may require implementation of special sequences. The
purpose of this study was to evaluate the need for accurate
bone segmentation in MR-based AC for whole-body PET/
MR imaging.
Methods In 22 patients undergoing sequential PET/CT and 3-
T MR imaging, modified CT AC maps were produced by
replacing pixels with values of >100 HU, representing mostly
bone structures, by pixels with a constant value of 36 HU
corresponding to soft tissue, thereby simulating current MR-
derived AC maps. A total of 141 FDG-positive osseous
lesions and 50 soft-tissue lesions adjacent to bones were
evaluated. The mean standardized uptake value (SUVmean)
was measured in each lesion in PET images reconstructed
once using the standard ACmaps and once using the modified
AC maps. Subsequently, the errors in lesion tracer uptake for
the modified PET images were calculated using the standard
PET image as a reference.
Results Substitution of bone by soft tissue values in AC
maps resulted in an underestimation of tracer uptake in
osseous and soft tissue lesions adjacent to bones of 11.2±
5.4 % (range 1.5–30.8 %) and 3.2±1.7 % (range 0.2–4 %),
respectively. Analysis of the spine and pelvic osseous
lesions revealed a substantial dependence of the error on
lesion composition. For predominantly sclerotic spine
lesions, the mean underestimation was 15.9±3.4 % (range
9.9–23.5 %) and for osteolytic spine lesions, 7.2±1.7 %
(range 4.9–9.3 %), respectively.
Conclusion CT data simulating treating bone as soft tissue
as is currently done in MR maps for PET AC leads to a
substantial underestimation of tracer uptake in bone lesions
and depends on lesion composition, the largest error being
seen in sclerotic lesions. Therefore, depiction of cortical
bone and other calcified areas in MR AC maps is necessary
for accurate quantification of tracer uptake values in PET/
MR imaging.
Keywords PET .MR . Attenuation correction . Bone
segmentation . CTsimulation
Introduction
Accurate attenuation correction (AC) is essential for quan-
titative analysis of PET tracer distribution, especially for
assessing treatment response and comparing PET/MR to
PET/CT data. AC of PET data based on MR images is
challenging [1]. In contrast to CT data which can be easily
transformed into attenuation coefficients for PET, intensity
values in MR images do not reflect the X-ray density of
tissues [2, 3]. Thus image processing of MR data is neces-
sary for the generation of AC maps. Proposed approaches to
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MR-based AC (MR AC) are tissue segmentation, the
use of atlases or templates and pattern recognition tech-
niques or a combination of these [4–7]. Tissue segmen-
tation has worked well in PET/CT; however, the lack
of cortical bone signal in currently available MR
sequences makes bone segmentation difficult. A remedy
might be provided by ultrashort or zero echo time sequences
[8, 9].
There are no substantial clinical data showing whether it
is necessary to segment bone in MR AC maps or whether
the stronger attenuation of the 511 keV photons by bone can
be replaced by the attenuation of soft tissue in such maps.
Some investigators state that segmentation of CT images
into three (background, lung and soft tissue) or four (back-
ground, lungs, fat and soft tissue) tissue classes to generate
attenuation maps does not substantially change PET data
compared to the use of standard CT AC with a mean under-
estimation of bone lesion SUV of 6.5 % and 8 %, respec-
tively [5, 6]. In contrast, a recent study has shown that
segmentation of whole-body CT data into four classes,
while neglecting bone, results in SUV errors of >10 % in
58 % of osseous lesions [7]. All these studies evaluated the
effects on a lesion by lesion basis, but did not consider that
bone lesion density can vary considerably spanning from
lytic to sclerotic.
In order to better understand the effects of bone atten-
uation using MR AC without bone segmentation, we
generated whole-body error maps using CT data that
allowed us to visualize the areas of the body in which
the resulting errors from ignoring bone in AC were
substantial or were only minimal.. Additionally, this ap-
proach allowed determination of the systematic error in
PET/MR compared to PET/CT when neglecting bone for
MR AC. Approaches for correcting for such errors may
be necessary because some patients will undergo PET/
MR and PET/CT examinations interchangeably for ther-
apy monitoring in the future.
Errors in SUV from MR AC ignoring bone not only
depend on the body region, but also on the density of the
bone lesions themselves. This in turn depends on the under-
lying disease process and may change significantly during
the course of a disease or after therapy. Frequently bone
lesions are initially lytic, but on follow-up examinations the
bone lesions may become sclerotic. These changes in lesion
density will not be evident when treating bone as soft tissue
in MR AC maps. The influence of the composition of bone
lesions on the errors in SUV in segmented AC approaches
has not been studied before.
The purpose of this study was therefore twofold: to
generate error maps to estimate the accuracy of bone seg-
mentation in MR AC for whole-body PET/MR imaging and
to specifically look at errors in bone lesions of various
compositions and lesions close to bone.
Materials and methods
Patients
This institutional review board-approved retrospective study
included 22 patients with osseous lesions and soft-tissue
lesions adjacent to bone who were selected from a total of
120 patients. All 22 patients underwent sequential PET/CT
and 3-T MR imaging between December 2010 and June
2011 as part of a clinical/research work-up. In this study,
only the PET/CT part of the studies was used. The patient
characteristics are summarized in Table 1.
Image acquisition
PET/CT imaging was performed on a full-ring, state-of-the
art time-of-flight PET/CT system (Discovery PET/CT 690;
GE Healthcare). Patients fasted for at least 4 h prior to
injection of a dose of 360.7±18 of 18F-FDG (Table 1). After
an uptake time of 60 min, native low-dose CT data and PET
emission data were acquired from the mid-thigh to the
vertex of the skull. CT data were acquired with 50–79
mAs per slice, 120 kVp, a pitch of 0.984:1, a collimation
of 64×0.625 mm, a measured FOV of 50 cm and a noise
index of 20 %, and were reconstructed to images of
0.625 mm transverse pixel size and 3.75 mm slice thickness.
PET data were acquired in 3-D mode with a fixed scan
duration of 2 min and an axial FOV of 153 mm per bed
position. Seven axial FOVs were used.
Reconstruction of attenuation maps
In each patient standard and modified CT AC maps were
generated by a trilinear transformation of non-enhanced
low-dose CT images to 511 keV PET attenuation maps [2].
According to the performed histogram analysis of CT
images (Fig. 1) the density cut-off for the bone tissue seg-
mentation was defined as 100 HU while the representative
density value for the soft tissue was set at 36 HU. Modified
AC maps (AC-Mod) were produced using PMOD software
(PMOD Technologies, Zurich, Switzerland) by replacing
pixels with values higher than 100 HU by pixels with a
Table 1 Patient characteristics
Characteristic Value
Number of patients 22
Age (years, mean ± SD) 58.2±14.9
Weight (kg, mean ± SD) 75.3±8.4
Male 16 (73 %)
18F-FDG dose (MBq, mean ± SD) 360.7±18
18F-FDG uptake time (min, mean ± SD) 62.2±3.6
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constant value of 36 HU, thereby simulating substitution of
bone by soft tissue in MR-derived segmented AC maps.
Standard AC maps (AC-St) were produced from the same
but unmodified non-enhanced low-dose CT images. Houns-
field units were transformed into 511 keV attenuation using
the following algorithm: AC [1/cm]0intercept + CT value *
slope. CT values below 50 HU were converted to attenua-
tion using the kVp-independent soft-tissue conversion with
an intercept of 0.096 and a slope of 9.6×10−5. CT values of
50 HU and above were converted using the 120-kVp bone
scale with an intercept of 0.0982 and a slope of 5.11×10−5.
Subsequently, two sets of attenuation-corrected PET images
were reconstructed based on the modified and standard AC
maps. An overview of the image reconstruction procedure is
given in Fig. 2.
Generation of a whole-body SUV error map
Whole-body maps showing the percentage differences in SUV
between PET images reconstructed using themodified ACmap
(PETAC-Mod) and the standard AC map (PETAC-St) were gener-
ated using the following formula: (PETAC-Mod−PETAC-St)/
PETAC-St×100 %. The resulting difference map was analysed
for body regions showing the largest differences in SUV.
Image analysis
First, the mean SUV of FDG avid lesions located in bone
and in soft tissues adjacent to bone (within 10 mm) were
measured by placing a volume of interest of 10 mm diameter
on PETAC-St and PETAC-Mod images. The volume of interest
was placed within PET-positive lesions of at least 1 cm3.
Subsequently, the standard error of SUVmean in the lesions
was calculated for the PETAC-Mod images using the PETAC-St
images as a reference. SUVmean rather than SUVmax was
measured because recent literature suggests that reporting
SUVmean gives results closer to reality than SUVmax
[10, 11]
Bone lesions were then divided into lesions involving
spine, pelvic bones and other bones. Spine and pelvic
lesions were further classified into three classes based on
their appearance on CT images: (1) lytic lesions showing
predominant and clearly visible destruction of osseous ma-
trix with CT density below 100 HU, (2) sclerotic lesions
showing predominantly increased bone density with CT
density above 200 HU, and (3) lesions of mixed density
showing a combination of destructive and sclerotic changes
or lesions without visible change in bone density on CT
images with a CT density in the range 100–200 HU. The
means and standard errors were similarly calculated for
these classes as for all bone lesions and for the various
anatomic locations (Table 2).
Fig. 1 Histogram analysis of
CT images. The density cut-off
for bone tissue segmentation
was defined based on this
histogram as 100 HU while that
for soft tissue was set at 36 HU
Fig. 2 Generation of AC maps followed by PET data reconstruction.
The modified CT data were generated by replacing all pixels in CT
sections with values >100 HU by pixels with a value of 36 HU. The
“no-bone” CT data obtained were then used for AC of PET images and
compared to the PET images which were AC-corrected in standard
mode
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Results
Analysis of the whole-body error maps showed that the largest
errors with an average of 15–20 % were present in bone
(Figs. 3 and 4). In the soft tissues the highest SUVerrors were
seen in the brain and tissues just adjacent to the bones (10–
15 %) with a rapid decrease in error magnitude with distance
from bone. Errors in other areas of the body SUVerror maps
were generally below 5 %. In addition to areas of underesti-
mation, regions of slight overestimation of SUV were also
identified in soft tissue on the SUV error maps (Fig. 3), but
again not exceeding 5 %. Bone lesions and soft-tissue lesions
adjacent to bone were quantitatively assessed for SUV errors
(Table 2). Quantitative analysis of brain lesions was not
performed as the focus was on body imaging and our series
contained only a single patient with a brain lesion. In Fig. 4,
axial images of a fusion of SUV error maps and original CT
images are shown with colour codes giving error ranges.
A total of 141 FDG-positive osseous lesions were found in
13 patients including 43 lesions in the vertebral bodies of the
thoracic and lumbar spine, 41 lesions in the pelvic bones and
57 lesions in other bones. Further analysis of the density of
vertebral body lesions on CT images revealed 23 sclerotic, 13
with normal or mixed density and 7 lytic lesions. In the pelvis,
17 sclerotic, 15 normal or mixed density and 9 lytic lesions
were found.
Substitution of bone by soft tissue density values in AC
maps resulted in a mean underestimation of SUV in all bone
Table 2 Summary of SUV
underestimation produced by
reconstruction of PET images
using modified AC maps
Location Number
of lesions
Mean
error ± SD (%)
Minimum
error (%)
Maximum
error (%)
Spine, vertebral bodies
Sclerotic 23 15.9±3.4 9.9 23.5
Mixed density 13 10.6±1.5 8.7 11.2
Lytic 7 7.2±1.7 4.9 9.3
Pelvic bones
Sclerotic 17 14.2±4 8.4 23.8
Mixed density 15 13.1±4.9 6.2 21.3
Lytic 9 6.8±2.7 3.1 12
Spine, vertebral processes 4 9.6±3.8 4.9 13.9
Sacrum 11 8.6±4.6 4.3 19.6
Sternum 7 8.5±2.5 4.8 11.3
Ribs 10 3±1 1.5 4.8
Scapula 3 7.7±3.3 4.8 11.1
Humerus 11 8.4±3 4 11
Femur 11 16.8±7 9.5 30.8
Total bone lesions 141 11.2±5.4 1.5 30.8
Soft-tissue lesions located near bone 50 3.2±1.7 0.2 4
Fig. 3 Example whole-body er-
ror maps in the sagittal (a) and
coronal (b) planes showing the
difference in percentage SUV
between PET images recon-
structed using modified AC
maps treating bone as soft tissue
and standard AC maps. Error
maps were generated
using the following formula:
(PETAC-Mod−PETAC-St)/
PETAC-St×100 %. While most
areas show SUV underestima-
tion (blue), there are also some
areas of slight SUVoverestima-
tion (red)
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lesions of 11.2±5.4 %. A minimum SUV underestimation of
1.5 % was seen in a rib lesion while a maximum SUV
underestimation of 30.8 % was identified in a sclerotic lesion
located in the femoral bone. A summary of SUVerrors in bone
lesions of different composition in various regions produced
by reconstruction of PET images using the modified ACmaps
is given in Table 2.
Analysis of 52 spine and 41 pelvic lesions revealed an
important dependence of the underestimation error on the
composition of the lesions, while this error was substantially
smaller in other lesions and thus not further analysed. For
predominantly sclerotic, normal/mixed density and lytic
lesions of the thoracic and lumbar spine vertebral bodies,
the underestimation errors were 15.9±3.4 % (mean ± SD,
range 23.5–9.9 %), 10.6±1.5 % (range 11.2–8.7 %) and
7.2±1.7 % (range 9.3–4.9 %), respectively. For osseous
lesions in the pelvis, the corresponding underestimation errors
for sclerotic, normal/mixed density and lytic lesions were
14.2±4 % (range 23.8–8.4 %), 13.1±4.9 % (range 21.3–
6.2 %) and 6.8±2.7 % (range 12–3.1 %), respectively.
A total of 50 FDG-positive lesions were identified in the
soft tissues adjacent to bony structures in six patients. In these
lesions, substitution of the bone by soft tissue values in the AC
maps resulted in underestimation errors of 3.2±1.7 % (mean ±
SD). Among these lesions, the smallest error of 0.2 % was
found in a lung lesion adjacent to a rib, while the largest error
of 4 % was seen in a lymph node adjacent to the osseous
pelvis.
Discussion
Decreases in SUV were highest for lesions within or next to
bone when PET images were reconstructed using a modified
AC map treating bone as soft tissue versus a standard AC map.
The magnitude of this error decreased rapidly with the distance
Fig. 4 Example axial images
through the base of the skull
(a, b), chest (c, d), abdomen
(e, f) and pelvis (g, h) showing
fusion of SUV error maps and
original CT images. The largest
underestimation in SUV is seen
in bone and rapidly decreases
from soft tissue adjacent to
bone (within 10 mm) to more
distant soft tissue. Of note, the
error is substantially larger in a
dense osteophyte in the right
anterior aspect of the thoracic
vertebral body shown (c, d)
compared to the other parts
of the vertebral body
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form bone and showed only a very small difference in other
areas of the body (brain not analysed in this study). Therefore
191 lesions, 141 in bone and 50 adjacent to bone were exam-
ined in more detail. Based on the analysis of the 141 FDG-
positive bone lesions, substitution of bone by soft tissue in AC
maps for PET resulted in average underestimation of SUV in
bones by around 10 %. Lesions located in the ribs showed an
average error below 5 %, while lesions located in the proximal
femur showed a larger average error of more than 15 %.
Importantly, in our study the maximum SUV underestimation
for bone lesions of more than 20 % was seen in dense sclerotic
lesions: 23.5% for spine lesions, 23.8% for pelvic bone lesions
and 30.8 % for femoral lesions.
Compared to the studies performed by Martinez-Möller et
al. [5] (21 osseous lesions with an average SUV change of 8±
3 % and maximal underestimation of 13.1 % seen in a lesion
in the pelvic bone) and by Schulz et al. [6] (7 bone lesions with
an average underestimation of 6.5±4.1 % and maximum error
of −13.4 % seen in a pelvic bone lesion), the average and
maximum errors seen in osseous lesions were significantly
higher in our study. The results of our study support the
findings of Hofmann et al. which showed tracer uptake
quantification errors of >10 % in 58 % of osseous lesions
and errors >20 % in 22 % of the lesions [7]. The difference in
the magnitude of underestimation may be explained by the
larger number of osseous lesions examined in our study (141),
and their location and composition. Additionally, another
important factor may be the different approaches to recon-
struction of the AC maps as we substituted only bone by soft
tissue values rather than using a full three- or four-class CT
segmentation. This approach allowed us to determine the
effect of bone attenuation by changing only one parameter.
The errors observed are of interest for understanding the
systematic errors in MR AC-based PET scans, but are par-
ticularly relevant when comparing the data obtained from
PET/CT and PET/MR for treatment response assessment. In
fact, an AC-induced 20–30 % error in SUVof a lesion might
change the assessment of treatment response.
To our knowledge this is the first study showing a substan-
tial difference in underestimation of SUV in PET between
dense sclerotic and destructive lytic bone lesionswhen neglect-
ing the bone in AC maps. The presence of 52 spine and 41
pelvic bone lesions allowed us to assess the dependence
of the error on the density of the bone lesions. We found a
substantial difference in SUV underestimation between the
sclerotic lesions with an average error of −15.9 % in spine
and −14.2 % in pelvic lesions and lytic lesions with respective
underestimation values of −7.2 % and −6.8 %. The commonly
used approach to MR-based AC is tissue segmentation with
substitution of bone by soft tissue values [5–7, 12, 13]. In bone
lesions with little or no change in density over the therapeutic
course, this type of segmentation will result only in a system-
atic under-correction of bone attenuation between consecutive
PET/MR scans and interpretation is not truly affected. How-
ever, the density of the bone lesions can change significantly
during the course of the disease—and this will have an impact
on their attenuation properties. Treating bone as soft tissue in
theMRACmaps of consecutive PET/MR scans performed for
assessment of treatment response may result in SUV differ-
ences solely due to changes in lesion density and not due to a
change in the metabolic activity of the lesion.
The magnitude of the SUV error of bone lesions is depen-
dent not only on their own density but also on the density of the
surrounding bones, being smaller in osteoporotic bones and
Fig. 5 A 70-year-old woman with a sclerotic bone metastasis of breast
cancer in thoracic vertebral body 10. a PET image reconstructed using the
standard CTACmap shows an FDG-avid lesion in the left anterior aspect
of T10. b Standard CTAC map shows that the bone lesion is sclerotic. c
PET image reconstructed using the modified CT AC map. d In the
modified CT AC map bone is substituted by soft tissue. In this case
modification of the AC map has resulted in underestimation of FDG
uptake by 23 % in this bone metastasis in the modified PET image
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larger in the presence of degenerative changes or in certain
disease states (e.g. myelofibrosis, mastocytosis, osteopetrosis).
Analysis of whole-body SUVerror maps also revealed an
underestimation of tracer uptake in soft tissues adjacent to
bone. Dedicated analysis of 48 soft tissue lesions in close
proximity to bone revealed that the errors were lower than
5 % (mean underestimation 3.2 %, maximum 4 %), which
for clinical purposes may be negligible. While our data do
not allow the relevance of skull bone for the AC of brain
lesions to be addressed, other authors have shown that this is
mandatory to quantify brain PET examinations [14]. In
addition to the SUV underestimation highlighted above,
minor SUVoverestimation was also seen in some soft tissue
regions. This is potentially due to differences caused by the
interaction between changes in attenuation and the scatter
correction of the data, but again is hardly clinically relevant.
In agreement with lesion-based evaluations of other studies
[5, 6], our AC maps suggest that for lesions in soft tissues, fat
or lung, the omission of bone from the AC of PET data is
clinically not relevant, at least at the levels of accuracy at
which SUV values are used nowadays. However, neglecting
bone can lead to relatively high SUV errors in lesions within
bone, especially in sclerotic areas. Therefore, in PET/MR, the
application of MR sequences able to depict bone might be
necessary not only for MR AC in brain tissue, but also for
lesions within bone throughout the body. In such lesions we
have no a priori knowledge without CT data if they are lytic,
sclerotic or mixed, and this can change during the course of a
disease, making therapy monitoring challenging when using
MR AC ignoring attenuation by bone.
Conclusion
Treating bone as soft tissue in MR-derived ACmaps for PET/
MR leads to a substantial underestimation of SUV values in
bone lesions. The errors depend substantially on lesion com-
position, with the largest error being seen in sclerotic lesions.
Therefore depiction of the cortical bone and sclerotic areas in
MRACmaps is necessary for accurate quantification of tracer
uptake values in whole-body PET/MR imaging.
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